Deep sequencing reveals complex mechanisms of microRNA deregulation in colorectal cancer

International Journal of Oncology

Volumn 45, Issue 2, 2014, Pages 603-610

  Gaofeng, Liang ^a,b   Li, Junsheng ^a   Sun, Bo ^a   Li, Shuchun ^a   Lü, Lanxin ^a   Wang, Yuanyuan ^a   Chen, Baoan ^a   Xiao, Zhongdang ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Colorectal cancer; Deep sequencing; microRNA; Regulation

Indexed keywords

MICRORNA; TRANSCRIPTOME;

ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; INTERACTIONS WITH RNA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA PROCESSING; RNA SEQUENCE; SIGNAL TRANSDUCTION; STATISTICAL MODEL; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; POLYMERASE CHAIN REACTION; PROCEDURES; SEQUENCE ANALYSIS;

COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICRORNAS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84902593365     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2474     Document Type: Article

References (44)

1. Weitz J, Koch M, Debus J, Höhler T, Galle PR and Büchler MW: Colorectal cancer. Lancet 365: 153-165, 2005. (Pubitemid 40091806)
2. Liefers GJ and Tollenaar R: Cancer genetics and their application to individualised medicine. Eur J Cancer 38: 872-879, 2002.
3. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
4. Wood LD, Parsons DW, Jones S, et al: The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113, 2007. (Pubitemid 350134889)
5. Alon U, Barkai N, Notterman DA, et al: Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 96: 6745-6750, 1999. (Pubitemid 29274954)
6. Williams NS, Gaynor RB, Scoggin S, et al: Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9: 931-946, 2003. (Pubitemid 36323695)
7. Lawrie CH: MicroRNAs and haematology: small molecules, big function. Br J Haematol 137: 503-512, 2007. (Pubitemid 46817340)
8. Wiemer EA: The role of microRNAs in cancer: No small matter. Eur J Cancer 43: 1529-1544, 2007.
9. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
10. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
11. Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005. (Pubitemid 40094598)
12. Akao Y, Nakagawa Y and Naoe T: MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 16: 845-850, 2006.
13. Schetter AJ, Leung SY, Sohn JJ, et al: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436, 2008. (Pubitemid 351185951)
14. Schepeler T, Reinert JT, Ostenfeld MS, et al: Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424, 2008.
15. Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM and Gao HJ: Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 11: 50-54, 2010.
16. Nagel R, le Sage C, Diosdado B, et al: Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 68: 5795-5802, 2008.
17. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, et al: MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 101: 707-714, 2009.
18. Schulte JH, Marschall T, Martin M, et al: Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma. Nucleic Acids Res 38: 5919-5928, 2010.
19. Li S, Wang H, Qi Y, et al: Assessment of nanomaterial cytotoxicity with SOLiD sequencing-based microRNA expression profiling. Biomaterials 34: 9021-9030, 2011.
20. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
21. Huang da W, Sherman BT, Tan Q, et al: DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 35: W169-W175, 2007.
22. Kal AJ, van Zonneveld AJ, Benes V, et al: Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources. Mol Biol Cell 10: 1859-1872, 1999. (Pubitemid 29272637)
23. Staub E, Gröne J, Mennerich D, et al: A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer. Mol Cancer 5: 37, 2006.
24. Zhang L, Huang J, Yang N, et al: microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103: 9136-9141, 2006. (Pubitemid 43902545)
25. Calin GA, Sevignani C, Dan Dumitru C, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004. (Pubitemid 38327724)
26. Ashburner M, Ball CA, Blake JA, et al: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29, 2000. (Pubitemid 30257031)
27. Callari M, Dugo M, Musella V, et al: Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues. PLoS One 7: e45105, 2012.
28. Drebber U, Lay M, Wedemeyer I, et al: Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Int J Oncol 39: 409-415, 2011.
29. Wong QW, Ching AK, Chan AW, et al: MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. Clin Cancer Res 16: 867-875, 2010.
30. Pineau P, Volinia S, McJunkin K, et al: miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 107: 264-269, 2010.
31. Ladeiro Y, Couchy G, Balabaud C, et al: MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47: 1955-1963, 2008. (Pubitemid 351952843)
32. Cho WC, Chow AS and Au JS: MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol 8: 125-131, 2011.
33. Arndt GM, Dossey L, Cullen LM, et al: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 9: 374, 2009.
34. Tan KS, Armugam A, Sepramaniam S, et al: Expression profile of MicroRNAs in young stroke patients. PLoS One 4: e7689, 2009.
35. Kohler JJ and Schepartz A: Kinetic studies of Fos.Jun.DNA complex formation: DNA binding prior to dimerization. Biochemistry 40: 130-142, 2001. (Pubitemid 32052684)
36. Bartlett DW and Davis ME: Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res 34: 322-333, 2006. (Pubitemid 43160055)
37. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ and Pandolfi PP: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465: 1033-1090, 2010.
38. Stefanius K, Ylitalo L, Tuomisto A, et al: Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma. Histopathology 58: 679-692, 2011.
39. Deschoolmeester V, Boeckx C, Baay M, et al: KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis. Br J Cancer 103: 1627-1636, 2010.
40. Bouchahda M, Karaboué A, Saffroy R, et al: Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis. Cancer Chemother Pharmacol 66: 605-609, 2010.
41. Kanehisa M and Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30, 2000. (Pubitemid 30047706)
42. Gidron Y, De Zwaan M, Quint K and Ocker M: Influence of stress and health-behaviour on miRNA expression. Mol Med Rep 3: 455-457, 2010.
43. Yu AM: Role of microRNAs in the regulation of drug metabolism and disposition. Expert Opin Drug Metab Toxicol 5: 1513-1528, 2009.
44. Li SC, Wang Y, Wang H, et al: MicroRNAs as participants in cytotoxicity of CdTe quantum dots in NIH/3T3 cells. Biomaterials 32: 3807-3814, 2011.